Concepedia

Saswata Talukdar

ST

Statistics

Publications

45

Citations

9.1K

H-Index

34

Active since

2006

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

University of California San Diego

Pfizer (United States)

Harvard University

Boston Children's Hospital

Saswata Talukdar is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in life sciences, insulin resistance, and cell signaling.

ORCID

Publications per year

2006–2024

45

Publications

45

GPR120 Is an Omega-3 Fatty Acid Receptor Mediating Potent Anti-inflammatory and Insulin-Sensitizing Effects

Da Young Oh, Saswata Talukdar, Eun Ju Bae et al. · Cell · 2010 · 2.4K citations · Full text

, , +12

Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase

Saswata Talukdar, Da Young Oh, Gautam Bandyopadhyay et al. · Nature Medicine · 2012 · 931 citations · Full text

, , +14

Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease

Gordon I. Smith, Mahalakshmi Shankaran, Mihoko Yoshino et al. · Journal of Clinical Investigation · 2019 · 728 citations · Full text

, , +17

Inflammation Is Necessary for Long-Term but Not Short-Term High-Fat Diet–Induced Insulin Resistance

Yun Sok Lee, Pingping Li, Jin Young Huh et al. · Diabetes · 2011 · 557 citations · Full text

, , +17

A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjects

Saswata Talukdar, Yingjiang Zhou, Dongmei Li et al. · Cell Metabolism · 2016 · 488 citations · Full text

, , +15

1–5 of 45